Search Results - "Guehennec, Jérémy"
-
1
ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma
Published in Journal of neuro-oncology (01-07-2018)“…ATP-binding cassette transporters (ABC transporters) regulate traffic of multiple compounds, including chemotherapeutic agents, through biological membranes…”
Get full text
Journal Article -
2
Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma
Published in Journal of neuro-oncology (01-08-2019)“…Introduction Glioblastoma (GBM) is the most common and aggressive primary brain cancer in adults. Few cytotoxic chemotherapies have been shown to be effective…”
Get full text
Journal Article -
3
Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
Published in Clinical cancer research (01-03-2016)“…p53 pathway alterations are key molecular events in glioblastoma (GBM). MDM2 inhibitors increase expression and stability of p53 and are presumed to be most…”
Get full text
Journal Article -
4
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Published in Expert review of neurotherapeutics (01-11-2016)“…Glioblastomas (GBM) are the most common and aggressive primary malignant brain tumors in adults. The blood brain barrier (BBB) is a major limitation reducing…”
Get more information
Journal Article -
5
Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors
Published in Neuro-oncology (Charlottesville, Va.) (01-02-2017)“…Glioblastoma (GBM) is the deadliest primary brain cancer in adults. Emerging innovative therapies hold promise for personalized cancer treatment. Improving…”
Get full text
Journal Article -
6
Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma
Published in Clinical and translational medicine (01-07-2022)“…Objective New therapeutic approaches are needed to improve the prognosis of glioblastoma (GBM) patients. Methods With the objective of identifying alternative…”
Get full text
Journal Article -
7
Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma
Published in Journal of neuro-oncology (01-07-2018)“…The names of authors Marc Sanson and Jean-Yves Delattre were incorrectly presented in the initial online publication. The original article has been corrected…”
Get full text
Journal Article -
8
EXTH-59. IDENTIFICATION OF GROWTH HORMONE RECEPTOR AS A RELEVANT TARGET FOR PRECISION MEDICINE IN LOW-EGFR EXPRESSING GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…New therapeutic approaches are needed to improve the prognosis of Glioblastoma (GBM) patients. With the objective of identifying alternative oncogenic…”
Get full text
Journal Article -
9
Brain distribution of the MDM2 inhibitor, RG7112: Single dose escalation and repeated doses studies
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
10
ET-62HIGHLY SELECTIVE ACTIVITY OF MDM2 INHIBITOR RG7112 AGAINST MDM2-AMPLIFIED/TP53 WILD-TYPE GLIOBLASTOMAS
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)“…Alteration of P53 pathway is one of the key molecular events involved in glioblastoma (GBM) biology. Genetic alterations which reduce TP53 function in GBM…”
Get full text
Journal Article -
11
ET-62 HIGHLY SELECTIVE ACTIVITY OF MDM2 INHIBITOR RG7112 AGAINST MDM2-AMPLIFIED/TP53 WILD-TYPE GLIOBLASTOMAS
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)“…Alteration of P53 pathway is one of the key molecular events involved in glioblastoma (GBM) biology. Genetic alterations which reduce TP53 function in GBM…”
Get full text
Journal Article -
12
GENO-33PATIENT DERIVED GLIOBLASTOMA CELL LINES RECAPITULATE PARENTAL TUMORS' MOLECULAR LANDSCAPE
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2015)Get full text
Journal Article